Neuros Medical, Inc.
Cleveland
Ohio
United States
27 articles about Neuros Medical, Inc.
-
Neuros Medical, Inc. Names David Veino as President and CEO and Expands Board of Directors
10/23/2023
Neuros Medical, Inc. today announced that David Veino has been appointed President and Chief Executive Officer.
-
Neuros Medical Announces Completion of QUEST Pivotal Trial 90-day Primary Endpoints
6/6/2022
Neuros Medical, Inc., a medical device company developing an innovative, on-demand bioelectric nerve block therapy for patients with intractable post-amputation pain, announced today the completion of its QUEST Pivotal Trial 90-day primary endpoints.
-
Neuros Medical Announces Completion of Enrollment in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain
9/15/2021
Neuros Medical, Inc. announced today the completion of enrollment in its pivotal QUEST (High-FreQUEncy Nerve Block for Po ST -Amputation Pain) study.
-
Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High Frequency Nerve Block System
6/29/2021
Neuros Medical, Inc., announced today that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the use of its novel High-Frequency Nerve Block system as an aid in the management of chronic intractable pain of the lower limb of adult amputees.
-
Neuros Medical Raises $38.5M in Series BB Funding for Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain
1/7/2021
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the close of a Series BB financing totaling $38.5 million .
-
Neuros Medical Announces Key Milestones in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain
1/7/2021
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the achievement of two milestones in its pivotal QUEST (High-Fre QUE ncy Nerve Block for Po ST -Amputation Pain) study. QUEST is a 180-sub
-
Neuros Medical, Inc. Taps Former Sequent Med Exec as New CEO
8/28/2017
-
Neuros Medical, Inc. Announces Closing of $20 Million Venture Financing
8/8/2017
-
Neuros Medical, Inc. Successfully Completes Interim Analysis Of Pivotal Study For Post-Amputation Pain
4/7/2016
-
Neuros Medical, Inc. Enrolls First Patients In Pivotal Study For Post-Amputation Pain
1/28/2015
-
Neuros Medical, Inc. Announces Issuance Of New U.S. Patent
5/22/2014
-
Neuros Medical, Inc. Receives Regulatory Approval to Conduct Pivotal Study
10/10/2013
-
Neuros Medical, Inc. Expands Clinical Advisory Board
8/14/2013
-
Neuros Medical, Inc.l Announces Successful Pilot Study: Data to Be Presented at International Neuromodulation Society’s World Congress
6/4/2013
-
Neuros Medical, Inc. Announces Successful Pilot Study: Data to be Presented at International Neuromodulation Society’s World Congress
6/4/2013
-
Neuros Medical, Inc. Develops Implantable Device for Chronic Pain Applications
1/7/2013
-
Neuros Medical, Inc. Awarded "Most Promising Startup" at 2012 Neurotech Leaders Forum
10/29/2012
-
Neuros Medical, Inc. Adds Vice President of Clinical and Regulatory Affairs to Management Team
10/8/2012
-
Neuros Medical, Inc. Raises Second Round of Funding
7/18/2012
-
Neuros Medical, Inc. Receives Regulatory Approval to Commence Pilot Study
11/29/2011